Request Demo
Last update 29 Aug 2025
Guangzhou Baiyunshan Bai Di Bio-technology Co., Ltd.
Last update 29 Aug 2025
Overview
Tags
Hemic and Lymphatic Diseases
Neoplasms
Colony-stimulating factors
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CN118056843
Patent MiningTarget |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20190561
评价冻干人用狂犬病疫苗（Vero细胞）免疫原性和安全性的随机、盲法、同类疫苗对照Ⅲ期临床试验
[Translation] A randomized, blinded, similar vaccine-controlled phase III clinical trial to evaluate the immunogenicity and safety of freeze-dried human rabies vaccine (Vero cells)
CTR20150842
治疗性双质粒HBV DNA疫苗治疗 HBeAg已发生血清学转换的慢性乙型肝炎的随机、双盲、对照、多中心Ⅱc期临床试验（方案B）
[Translation] A randomized, double-blind, controlled, multicenter phase IIc clinical trial of a therapeutic dual-plasmid HBV DNA vaccine for the treatment of chronic hepatitis B with HBeAg seroconversion (scheme B)
CTR20150841
治疗性双质粒HBV DNA疫苗治疗 HBeAg未发生血清学转换的慢性乙型肝炎的随机、双盲、对照、多中心Ⅱc期临床试验 （方案A）
[Translation] A randomized, double-blind, controlled, multicenter phase IIc clinical trial of a therapeutic dual-plasmid HBV DNA vaccine for the treatment of chronic hepatitis B in patients without HBeAg seroconversion (Scheme A)
100 Clinical Results associated with Guangzhou Baiyunshan Bai Di Bio-technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Guangzhou Baiyunshan Bai Di Bio-technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Guangzhou Baiyunshan Bai Di Bio-technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 29 Aug 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
NDA/BLA
Approved
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free